Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3211-3229
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3211
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3211
Figure 1 The olfactomedin 4/nucleotide-binding oligomerization domain 1/caudal-type homeobox gene 2 pathway is a characteristic of gastric intestinal metaplasia tissues.
A: The representative images of Immunohistochemistry (IHC) staining for olfactomedin 4 (OLFM4), nucleotide-binding oligomerization domain 1 (NOD1), and caudal-type homeobox gene 2 (CDX2) in normal and intestinal metaplasia (IM) tissues; B: OLFM4, NOD1, and CDX2 immunoreactivity scores in normal and IM tissues were compared; C: Correlation of OLFM4 with CDX2, NOD1 with CDX2, and OLFM4 with NOD1 in gastric tissues by Spearman’s correlation analysis. aP < 0.01, bP < 0.001 vs control group. OLFM4: Olfactomedin 4; NOD1: Nucleotide-binding oligomerization domain 1; CDX2: Caudal-type homeobox gene 2; IM: Intestinal metaplasia.
- Citation: Zhou DS, Zhang WJ, Song SY, Hong XX, Yang WQ, Li JJ, Xu JQ, Kang JY, Cai TT, Xu YF, Guo SJ, Pan HF, Li HW. Weiwei Decoction alleviates gastric intestinal metaplasia through the olfactomedin 4/nucleotide-binding oligomerization domain 1/caudal-type homeobox gene 2 signaling pathway. World J Gastrointest Oncol 2024; 16(7): 3211-3229
- URL: https://www.wjgnet.com/1948-5204/full/v16/i7/3211.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.3211